The ethical and scientific case for phase 2C clinical trials

Ying-Kiat Zee*, Sarah W. Chan, John Harris, Gordon C. Jayson

*Corresponding author for this work

Research output: Contribution to journalEditorial

Original languageEnglish
Pages (from-to)410-411
Number of pages2
JournalThe Lancet Oncology
Volume11
Issue number5
Publication statusPublished - 1 May 2010

Cite this